Cipro is one of a number of fluoroquinolone antibiotics that are the subject of lawsuits involving peripheral neuropathy and permanent nerve damage. Plaintiffs who have filed Cipro lawsuits accuse the drug’s manufacturer of downplaying its association with debilitating nerve damage for years, and placing the need for profit well above consumer safety. If you suffered similar harm while undergoing treatment with Cipro, filing your own claim could allow you to obtain compensation for your pain and suffering, as well as any financial damages incurred as a result of your injuries, including medical bills and lost wages.
Bernstein Liebhard LLP is now providing free, no obligation case reviews to individuals who were diagnosed with permanent nerve damage or peripheral neuropathy while undergoing treatment with Cipro or any other fluoroquinolone antibiotic. If you would like to learn whether or not you could be eligible to file a product liability lawsuit against the manufacturer of Cipro, please contact our office today by calling .
Along with Levaquin, Cipro is the most commonly prescribed fluoroquinolone antibiotic. In 2011, some 16 million people received prescriptions for Cipro tablets, while millions more were treated with the medication via an IV while hospitalized. Cipro became particularly famous in 2001, after it was used to treat the victims of that year’s anthrax attacks. Like other drugs in this class, Cipro is an extremely potent medication, and its use should be reserved for the most serious types of bacterial infections. This is due to the potential for antibiotic resistance, as well as the drug’s association with certain serious complications, including nerve damage and tendon injuries.
Since the 1990s, researchers have been aware of evidence linking drugs like Cipro to serious nerve damage, but information about peripheral neuropathy wasn’t added to the medication’s label until 2004. In 2013, after determining that the original warnings did not adequately describe the rapid onset and potentially-permanent nature of Cipro-associated nerve damage, the U.S. Food & Drug Administration (FDA) ordered that stronger language be added to all fluoroquinolone labels. “In some patients the symptoms had been ongoing for more than a year despite discontinuation of the fluoroquinolone,” the FDA noted at the time. “Several patients were continued on the fluoroquinolone drug despite the occurrence of neuropathic symptoms.”
The new Cipro label warned that the onset of nerve damage can occur within just a few days of the start of treatment, and that peripheral neuropathy may be long-lasting or permanent. As such, patients taking Cipro should contact their doctor immediately if they experience symptoms of pain, numbness, burning, itching, weakness in the arms and legs, or any changes in sensation like pain, body position, vibration or temperature.
An experienced drug injury lawyer can help you determine whether or not you might be eligible to file a Cipro lawsuit for peripheral neuropathy or permanent nerve damage. The attorneys at Bernstein Liebhard LLP are available now to evaluate your potential claim for free, and will take the time help you understand the process involved in filing a lawsuit against the manufacturer of Cipro. To learn more, please call our office at .